{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:20:22Z","timestamp":1789129222970,"version":"build-2803163510"},"reference-count":48,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.2217\/imt.15.108","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T16:49:10Z","timestamp":1453135750000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Role of Inotuzumab Ozogamicin in the Treatment of Relapsed\/Refractory Acute Lymphoblastic Leukemia"],"prefix":"10.1080","volume":"8","author":[{"given":"Binsah","family":"George","sequence":"first","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Centre, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Centre, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Centre, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Centre, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,1,18]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.38"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70191-X"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20668"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70188-X"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-018192"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.007"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2958"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-261586"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1287"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21776"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.6768"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.559668"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2466"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.529206"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00801.x"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.481"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-013-0016-7"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290021380"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3179"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.206"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2002.01063.x"},{"issue":"13","key":"e_1_3_3_24_1","first-page":"3062","article-title":"Processing of antibodies bound to B-cell lymphomas and other hematological malignancies","volume":"56","author":"Hanna R","year":"1996","unstructured":"Hanna R , OngGL, MattesMJ. Processing of antibodies bound to B-cell lymphomas and other hematological malignancies. Cancer Res.56(13), 3062\u20133068 (1996).","journal-title":"Cancer Res."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404866"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1342-9"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1905"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1134"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0486"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12408"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3240341"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.679359"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3534"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.823493"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3np20113a"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3197"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403350"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1024652"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.0132"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.09.014"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.1382"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.1900"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28136"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70386-2"},{"key":"e_1_3_3_45_1","first-page":"40","article-title":"Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia","volume":"6","author":"Jain N","year":"2014","unstructured":"Jain N , O\u2019BrienS, ThomasD, KantarjianH. Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia. Front. Biosci. (Elite Edition)6, 40\u201345 (2014).","journal-title":"Front. Biosci. (Elite Edition)"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.12.003"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24721"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23901"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3906.3906"},{"issue":"21","key":"e_1_3_3_50_1","first-page":"a794","article-title":"Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients (= 60 years) with acute lymphoblastic","volume":"124","author":"Jabbour E","year":"2014","unstructured":"Jabbour E , O\u2019BrienS, ThomasDAet al. Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients (= 60 years) with acute lymphoblastic. Leukemia124(21), a794 (2014).","journal-title":"Leukemia"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.15.108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:34:35Z","timestamp":1715996075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.15.108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,18]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.2217\/imt.15.108"],"URL":"https:\/\/doi.org\/10.2217\/imt.15.108","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}